Goldman Sachs
ARTL icon

Goldman Sachs’s Artelo Biosciences ARTL Stock Holding History

Goldman Sachs’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53
Closed -$17K – 5289
2020
Q2 		$17K Hold
53
– – ﹤0.01% 5134
2020
Q1 		$14K Hold
53
– – ﹤0.01% 5150
2019
Q4 		$38K Sell
53
-5
-9% -$3.06K ﹤0.01% 5139
2019
Q3 		$34K Buy
+58
New +$44.2K ﹤0.01% 5076

Goldman Sachs's ARTL Position: Q3 2020 in Review

Goldman Sachs sold out of Artelo Biosciences (ARTL) in Q3 2020, closing a stake of 53 shares — an estimated $17K sold.

Goldman Sachs first reported a position in ARTL in Q3 2019 and held it in 4 quarters. The position peaked at $38K in Q4 2019. 1 fund tracked by Wall St. Rank holds ARTL as of Q3 2020.

  • Goldman Sachs reported no remaining Artelo Biosciences position as of Q3 2020 after selling out during the quarter.
  • Goldman Sachs sold 53 Artelo Biosciences shares in Q3 2020, an estimated $17K.
  • Goldman Sachs first reported a position in Artelo Biosciences in Q3 2019 and held it in 4 quarters.
  • Goldman Sachs's Artelo Biosciences position peaked at $38K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Artelo Biosciences as of Q3 2020.

Based on Goldman Sachs's 13F filing for Q3 2020, filed 13 Nov 2020.